Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-fructofuranosidase (EC 3.2.1.26), also commonly called invertase, is an enzyme that catalyzes the hydrolysis of sucrose into glucose and fructose by cleaving the terminal non-reducing β-D-fructofuranoside residues in β-D-fructofuranosides[2][3][10]. It is widely used in the food industry for the production of invert sugar syrups, in baking, for sucrose-based fermented beverages, and other processes[2][3]. The most common industrial source is the yeast Saccharomyces cerevisiae, though it can also be produced by various fungi and bacteria[6][9]. The enzyme is generally recognized as safe, with a very low risk of allergenicity though cross-reactivity in tomato-allergic individuals has been documented[3][5]. It is not a direct therapeutic target in medicine but is crucial industrially for carbohydrate modification and processing.
Catalyzes the hydrolysis of terminal non-reducing β-D-fructofuranoside residues in β-D-fructofuranosides, mainly sucrose, releasing fructose and glucose[1][2][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-fructofuranosidase.